Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Clinical trial NCT07365358 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07365358
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.